Study of Insulin-like Growth Factor (IGF)-Methotrexate Conjugate in the Treatment of Advanced Tumors Expressing IGF-1R

Clinical trial NCT02045368 · COMPLETED

Trial details

NCT number: NCT02045368
Sponsor: IGF Oncology, LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Breast Cancer Brain Cancer Gastrointestinal Cancers Genitourinary Cancers Gynecologic Cancers Head and Neck Cancers Melanoma Thoracic Cancers

Start date: 2014-01-28
Primary completion: 2016-09-30
Enrollment: 92

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.